Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation

Blood

Volumn 112, Issue 8, 2008, Pages 3082-3087

  Arulogun, Suzanne O ^a,b   Prince, H Miles ^a,c   Ng, Jonathan ^d   Lade, Stephen ^e   Ryan, Gail F ^a,c   Blewitt, Odette ^a   McCormack, Christopher ^c,d  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e Department of Pathology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SEZARY SYNDROME; SKIN BIOPSY; AGED; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; REGISTER; RETROSPECTIVE STUDY; SKIN TUMOR; TREATMENT OUTCOME;

AGED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 54049111440     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-154609     Document Type: Article

References (16)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
2. Lamberg SI, Bunn PA Jr. Cutaneous T-cell lymphomas: summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979;115:1103-1105.
3. Kim YH, Liu HL Mraz-Gernhard S, Varghese A. Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol. 2003;139:857-866.
4. de Coninck EC, Kim YH, Varghese A, Hoppe RT. Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. J Clin Oncol. 2001;19:779-784.
5. Salhany KE, Cousar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous Tcell lymphoma to large cell lymphoma: a clinicopathologic and immunologic study. Am J Pathol. 1988;132:265-277.
6. Greer JP, Salhany KE, Cousar JB, et al. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol. 1990;8:215-227.
7. Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 1998;92:1150-1159.
8. Vergier B, de Muret A, Bey lot-Barry M, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. Blood. 2000;95:2212-2218.
9. Braverman IM, Redfern CPF Transformation in cutaneous T-cell lymphoma. J Invest Dermatol. 1993;101:249-251.
10. Cerroni L, Rieger E, Hodl S, Kerl H. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol. 1992;16:543-552.
11. Cerroni L, Gatter K, Kerl H. An Illustrated Guide to Skin Lymphoma, 2nd ed. Oxford, United Kingdom: Blackwell; 2004.
12. Wood GS. Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994;103:34-41.
13. Wolfe JT Chooback L, Finn DT, Jaworsky C, Rook AH, Lessin SR. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. J Clin Oncol. 1995;13:1751-1757.
14. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007; 110:1713-1722.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457.
16. van Doom R, van Haselen CW, van Voorst Vader PC, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000:136:504-510.